Table 3.
Influence of physical activity on the lipid profile
| Initially non-sportive (n=42) | Initially sportive (n=56) | ||||
|---|---|---|---|---|---|
| Group 1 (n=21) | Group 2 (n=21) | Group 3 (n=27) | Group 4 (n=29) | ||
| HDL baseline | 59±27 | 52±13 | 61±12 | 61±16 | |
| HDL 2 months | 59±28 | 55±15 | 67±15 | 63±18 | |
| HDL4 months | 64±28 | 54±17 | 65±12 | 64±17 | |
| HDL 6 months | 63±24 | 53±14 | 66±14 | 61±15 | |
| HDL 8 months | 60±23 | 57±16 | 65±14 | 63±18 | |
| p-value | 0.710 | 0.004 | 0.064 | 0.370 | |
| SAA baseline | 0.11±0.05 | 0.11±0.07 | 0.10±0.07 | 0.08±0.05 | |
| SAA 4 months | 0.12±0.07 | 0.10±0.06 | 0.10±0.06 | 0.08±0.06 | |
| SAA 8 months | 0.11±0.06 | 0.10±0.06 | 0.10±0.06 | 0.08±0.05 | |
| p-value | 0.769 | 0.484 | 0.839 | 0.297 | |
| SPB baseline | 0.15±0.08 | 0.13±0.09 | 0.14±0.06 | 0.13±0.08 | |
| SPB 4 months | 0.16±0.08 | 0.13±0.08 | 0.15±0.07 | 0.14±0.08 | |
| SPB 8months | 0.16±0.08 | 0.12±0.07 | 0.15±0.07 | 0.14±0.08 | |
| p-value | 0.454 | 0.209 | 0.588 | 0.173 | |
| ApoA1 baseline | 157±42 | 146±24 | 159±18 | 157±22 | |
| ApoA1 2 months | 161±41 | 155±31 | 171±23 | 164±28 | |
| ApoA1 4 months | 165±37 | 161±40 | 170±19 | 164±28 | |
| ApoA1 6 months | 170±37 | 155±36 | 171±24 | 161±23 | |
| ApoA1 8 months | 162±32 | 160±36 | 170±23 | 164±24 | |
| p-value | 0.156 | 0.002 | 0.025 | 0.040 | |
| ApoB baseline | 103±29 | 110±22 | 96±19 | 102±29 | |
| ApoB 2 months | 111±36 | 108±25 | 104±26 | 102±24 | |
| ApoB 4 months | 102±31 | 109±18 | 103±21 | 99±26 | |
| ApoB 6 months | 106±39 | 104±23 | 100±21 | 95±24 | |
| ApoB 8 months | 104±32 | 103±24 | 97±19 | 97±24 | |
| p-value | 0.910 | 0.101 | 0.674 | 0.096 | |
Table 3 shows HDL, SAA, SPB, ApoA1 and ApoB levels at the different points of measurement and p-values of the significance between the first and last point of measurement. HDL: high-density lipoprotein; SAA: serum amyloid A; SPB: surfactant protein B; Apo: apolipoprotein